CorMedix Inc.
300 Connell Drive, Suite 4200
Berkeley Heights, NJ 07922
October 7, 2025
Division of Corporation Finance
Securities & Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-3561
| Re: | CorMedix Inc. (CIK: 0001410098) |
| Form S-3ASR | |
| Filed on October 6, 2025 | |
| File No. 333-290721 |
Pursuant to Rule 477 under the Securities Act of 1933, as amended, CorMedix Inc. (the “Registrant”) hereby requests the withdrawal, effective immediately, of Registration Statement on Form S-3ASR, File No. 333-290721 (the “Registration Statement”), which was originally filed by the Registrant with the Securities and Exchange Commission (the “Commission”) on October 6, 2025. The Registration Statement inadvertently omitted current dates from the exhibits incorporated into such filing. The Registration Statement will be refiled on EDGAR promptly, with the corrected dates for such exhibits.
The Company confirms that no securities have been sold under the Registration Statement. The Company understands that, pursuant to Rule 477(b) under the Securities Act, this application for withdrawal will be effective at the time filed with the Commission unless, within fifteen calendar days after the filing, the Commission notifies the Company that the application for withdrawal will not be granted.
Please direct any questions or comments regarding this correspondence to Andrew Marmer of Willkie Farr & Gallagher, LLP, at (212) 728-8847. Thank you for your assistance in this matter.
| Respectfully submitted, | ||
| By: | /s/ Beth Zelnick Kaufman | |
| Name: | Beth Zelnick Kaufman | |
| Title: | Chief Legal and Compliance Officer and Corporate Secretary | |